Abstract
Some commonly used H2-receptor antagonists affect gastric first-pass metabolism of ethanol and lead to unexpectedly high blood alcohol concentrations after consumption of alcohol. To investigate whether omeprazole-a substituted benzimidazole recently approved for clinical use-has a similar harmful effect, we administered a moderate dose of ethanol (0.3 g/kg body wt) orally to seven normal volunteers before and after one week of omeprazole administration (20 mg daily). No significant effect of the drug was found on either mean peak blood alcohol concentrations or on areas under the blood alcohol curve; neither did these parameters differ significantly before or after an acute dose of omeprazole (13.2 mg/kg body wt) in rats, whether ethanol (0.25 g/kg body wt) was administered intragastrically or intravenously.In vitro, omeprazole in concentrations likely to occur in the gastric lumen (0.01–1.0 mM), did not affect gastric alcohol dehydrogenase activity of humans or rats. Thus omeprazole does not affect gastric first-pass metabolism of ethanol and can be considered as a safe choice for the treatment of patients who do not refrain from alcohol consumption during therapy.
Similar content being viewed by others
References
Julkunen RJK, DiPadova C, Lieber CS: First pass metabolism of ethanol—a gastrointestinal barrier against the systemic toxicity of ethanol. Life Sci 37:567–573, 1985
Julkunen RJK, Tannenbaum L, Baraona E, Lieber CS: First pass metabolism of ethanol: an important determinant of blood levels after alcohol consumption. Alcohol 2:437–441, 1985
DiPadova C, Worner TM, Julkunen RJK, Lieber CS: Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol. Gastroenterology 92:1169–1173, 1987
Frezza M, DiPadova C, Pozzato G, Terpin M, Baraona E, Lieber CS: High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and firstpass metabolism. N Engl J Med 322:95–99, 1990
Caballería J, Baraona E, Rodamilans M, Lieber CS: Effects of cimetidine on gastric alcohol dehydrogenase activity and blood ethanol levels. Gastroenterology 96:388–392, 1989
Hernández-Muñoz R, Caballería J, Baraona E, Uppal R, Greenstein R, Lieber CS: Human gastric alcohol dehydrogenase and its effect on bioavailability of ethanol. Alcoholism: Clin Exp Res 14:946–950, 1990
Caballería J, Baraona E, Deulofeu R, Hernández-Muñoz R, Rodés J, Lieber CS: Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. Dig Dis Sci 36:1673–1679, 1991
Feely J, Wood AJJ: Effects of cimetidine on the elimination and actions of ethanol. JAMA 247:2819–2821, 1982
Seitz HK, Veith S, Czygan P, Bösche J, Simon B, Gugler R, Kommerell B:In vivo interactions between H2-receptor antagonists and ethanol metabolism in man and in rats. Hepatology 4:1231–1234, 1984
Palmer RH, Frank WO, Nambi P, Wetherington JD, Fox MJ: Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol. Am J Gastroenterol 86:1749–1755, 1991
DiPadova C, Roine R, Frezza M, Gentry RT, Baraona E, Lieber CS: Effects of ranitidine on blood alcohol levels after ethanol ingestion. JAMA 267:83–86, 1992
Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjöstrand S-E, Wallmark B: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H++K+)ATPase. Nature 20:159–160, 1981
Walt RP, Gomes M de FA, Wood EC, Logan LH, Pounder RE: Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J 287:12–14, 1983
Lauritsen K, Rune SJ, Bytzer P, Kelbaek H, Jensen KG, Rask-Madsen J, Bendtsen F, Linde J, Hojlund M, Andersen HH, Mollman KM, Nissen VR, Ovesen L, Schlichting P, Tage-Jensen U, Wulff HR: Effects of omeprazole and cimetidine on duodenal ulcer. N Engl J Med 312:958–961, 1985
Klinkenberg-Knol EC, Jansen JMBJ, Festen HPM, Meuwissen SGM, Lamers CBHW: Double-blind multicenter comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1:349–351, 1987
Archambault AP, Pare P, Bailey RJ, Navert H, Williams CN, Freeman HJ, Baker SJ, Marcon NE, Hunt RH, Sutherland L, Kepkay DL, Saibil FG, Hawken K, Farley A, Levesque D, Ferguson J, Westin JA: Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 94:1130–1134, 1988
Sandmark S, Carlsson R, Fausa O, Lundell L: Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 23:625–632, 1988
Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB, Fenger C, Hanberg-Sorensen F, Lauritsen K: Omeprazole and ranitidine in treatment of reflux oesophagitis: Double blind comparative trial. Br Med J 296:89–92, 1988
Korsten MA, Matsuzaki S, Feinman L, Lieber CS: High blood acetaldehyde levels after ethanol administration. Difference between alcoholic and nonalcoholic subjects. N Engl J Med 292:386–389, 1975
Rangno RE, Kreeft JH, Sitar DS: Ethanol “dose dependent” elimination: Michaelis-Menten v classical kinetic analysis. Br J Clin Pharmacol 12:667–673, 1981
Zar JH: Biostatistical Analysis, 2nd ed. Englewood Cliffs, New Jersey, Prentice-Hall, 1984
Larsson H, Carlsson E, Junggren U, Olbe L, Sjöstrand SE, Skånberg I, Sundell G: Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85:900–907, 1983
Seitz HK, Simanowski UA, Simon B, Kommerell B: Effect of omeprazole on ethanol oxidation and aniline hydroxylation in rat hepatic microsomes. Z Gastroenterol 26:188–190, 1988
Moreno A, Parés X: Purification and characterization of a new alcohol dehydrogenase from human stomach. J Biol Chem 266:1128–1133, 1991
Cederbaum AI, Pietrusko R, Hempel J, Becker FF, Rubin E: Characterization of a nonhepatic alcohol dehydrogenase from rat hepatocellular carcinoma and stomach. Arch Biochem Biophys 171:348–360, 1975
Julià P, Farrés J, Parés X: Characterization of three isoenzymes of rat alcohol dehydrogenase: Tissue distribution and physical and enzymatic properties. Eur J Biochem 162:179–189, 1987
Horowitz M, Hetzel DJ, Buckle PJ, Chatterton BE, Shearman DJC: Effect of omeprazole on gastric emptying in patients with duodenal ulcer disease. Br J Clin Pharmacol 18:791–794, 1984
Larsson H, Mattson H, Sundell G, Carlsson E: Animal pharmacodynamics of omeprazole. A survey of its pharmacological propertiesin vivo. Br J Gastroenterol 20(suppl 108): 23–35, 1985
Regardh CG, Gabrielsson M, Hoffman KJ, Löfberg I, Skanberg I. Pharmacokinetics and metabolism of omeprazole in animals and man—an overview. Scand J Gastroenterol 20(suppl 108):79–94, 1985
Helander HF, Ramsay CH, Regardh CG: Localization of omeprazole and metabolites in the mouse. Scand J Gastroenterol 20(suppl 108):95–104, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roine, R., Hernández-Muñoz, R., Baraona, E. et al. Effect of omeprazole on gastric first-pass metabolism of ethanol. Digest Dis Sci 37, 891–896 (1992). https://doi.org/10.1007/BF01300387
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01300387